BioCentury
ARTICLE | Clinical News

99mTc-MIP-1404: Phase I data

July 15, 2013 7:00 AM UTC

An open-label, U.S. Phase I trial in about 24 prostate cancer patients scheduled for prostatectomy and/or extended pelvic lymph node dissection showed that a single IV dose of 99mTc-MIP-1404 was well ...